| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/02/2004 | US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
| 03/02/2004 | US6699861 Anti-quinazoline compounds |
| 03/02/2004 | US6699858 Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 03/02/2004 | US6699856 Pyrazinones, compositions containing such compounds and methods of use |
| 03/02/2004 | US6699853 Protecting useful plants against the undesirable action of harmful insects, acarids and nematodes, |
| 03/02/2004 | US6699818 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 03/02/2004 | US6699651 Base precursors for use in a photothermographic element |
| 03/02/2004 | US6699298 Long chain hindered amines and compositions stabilized therewith |
| 03/02/2004 | CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/26/2004 | WO2004016741A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use |
| 02/26/2004 | WO2004016607A1 Inhibition of phosphoinositide 3-kinase beta |
| 02/26/2004 | WO2004016606A1 Pyrazole inhibitors of the transforming growth factor |
| 02/26/2004 | WO2004016605A1 2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists |
| 02/26/2004 | WO2004016604A2 Azabicyclic compounds are central nervous system active agents |
| 02/26/2004 | WO2004016597A2 Protein kinase inhibitors and uses thereof |
| 02/26/2004 | WO2004016596A1 Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders |
| 02/26/2004 | WO2004016592A1 Prenylation inhibitors and methods of their synthesis and use |
| 02/26/2004 | WO2004016587A1 Nitrogen-containing compounds |
| 02/26/2004 | WO2004016569A1 Process for the reduction of sulphoxides to sulphides |
| 02/26/2004 | WO2003101444A8 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer |
| 02/26/2004 | WO2003099211A3 Mitotic kinesin inhibitors |
| 02/26/2004 | WO2003097855A3 Small molecule inhibitors of her2 expression |
| 02/26/2004 | WO2003097564A3 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 02/26/2004 | WO2003096991A3 Amelioration of the development of cataracts and other opthalmic diseases |
| 02/26/2004 | WO2003086271A3 Azole derivatives as antifungal agents |
| 02/26/2004 | WO2003076398A3 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2003051837A3 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 02/26/2004 | WO2003050261A3 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
| 02/26/2004 | WO2002098869A3 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 02/26/2004 | WO2002094322A3 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 02/26/2004 | WO2002041910A8 Methods and compositions for the treatment of diseases of the eye |
| 02/26/2004 | US20040039198 Administering to a mammal an aromatic and heteroacromatic substituted imidazole compound to treat diseases: renal disease, wound healing, ucler, ocular disorder, diabetic nephropathy, atherosclerosis, fibrosis, ALzheimer's disease |
| 02/26/2004 | US20040039045 (2-azabicyclo(2.2.1)hept-7yl)methylcarbamate derivatives are useful for treating schizophrenia, Alzheimer's disease, neurodegenerative disorders, Parkinson's disease, Tourette's syndrome, age related memory loss and withdrawal symptoms |
| 02/26/2004 | US20040039044 Coupling under reducing conditions aminoalkylpyrrolidine-n-alkyl with one equivalant of a aldehyde compound; useful for treating pain, schizophrenia, depression and sleep disorders |
| 02/26/2004 | US20040039040 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 02/26/2004 | US20040039033 Administering (1-phenyl-2-heteroaryl)ethyl-guanidine compounds for treating ischemic conditions including myocardial infarction, congestive heart failure, and cardiac arrhythmias |
| 02/26/2004 | US20040039028 Nitrogen compounds such as 3,5-dichloro-2-fluoro-4-(3-isoprop -yl-4-methoxyphenoxy)-6-methoxycarbonylmethylaminopyridine, administered for prophylaxis of metabolic disorders |
| 02/26/2004 | US20040039027 Sulfur compounds such as (2-(((3-Methyl-4-(2,2,2-trifluoro-ethoxy)-2-pyridinyl)methyl)sulfinyl)-1H -benzimidazol-1-yl) methyl benzoate, administered as prodrugs for lansoprazole; proton pump inhibitors; gastrointerstinal disorders |
| 02/26/2004 | US20040039025 Substituted hydrazine derivatives |
| 02/26/2004 | US20040039019 Hetreocyclic carboxy amines such as N-(2-Oxo-2,3-dihydro-1H-indol-6-yl)-2-((6-oxo-1,6-dihydro-pyridin-3 -ylmethyl)-amino)-benzamide, used for prophylaxis of arthritis, vision defects, diabetes, arteriosclerosis, skin or urogenital disorders |
| 02/26/2004 | US20040039017 Heterocyclic amines such as 2-(3-(4-Chloro-3-trifluoromethyl-benzylamino)prop-1-ylamino)-1H-quinolin-4 -one, used as G-protein coupled receptor inhibitors, for prophylaxis of cardiovascular disorders, schizophrenia or diabetes |
| 02/26/2004 | US20040039005 HIV replication inhibiting pyrimidines |
| 02/26/2004 | US20040039002 6,7-Dimethoxyquinazolines and therapeutic use thereof |
| 02/26/2004 | US20040038998 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity |
| 02/26/2004 | US20040038994 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/26/2004 | US20040038991 Imidazolyl-cyclic acetals |
| 02/26/2004 | US20040038988 Novel crystalline forms of gatifloxacin |
| 02/26/2004 | US20040038987 Novel cyclic diamine compounds and medicine containing the same |
| 02/26/2004 | US20040038986 E.g., 4-(6-chloronaphthalene-2-sulfonyl)-1-(4-methoxy-carbonylamino-1-(4 -pyridyl)piperidin-4-ylmethyl)-2-piperazinone; blood coagulation factor X inhibitors |
| 02/26/2004 | US20040038981 Novel Process |
| 02/26/2004 | US20040038979 Novel 6-heteroarylphenanthridines |
| 02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
| 02/26/2004 | US20040038975 Effective against a broad range of pathogenic microorganisms with advantages in low susceptibility to microbial resistance, reduced toxicity, and improved pharmacology. |
| 02/26/2004 | US20040038973 Treating osteoarthritis or rheumatoid arthritis |
| 02/26/2004 | US20040038972 1,3,5-Triazine derivatives as ligands for human adenosine-A3 receptors |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038966 Cyclic amine derivatives and use thereof |
| 02/26/2004 | US20040038964 Imidazole derivatives as raf kinase inhibitors |
| 02/26/2004 | US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/26/2004 | US20040038959 Treating osteoarthritis or rheumatoid arthritis |
| 02/26/2004 | US20040038958 Topical treatment of skin diseases |
| 02/26/2004 | US20040038943 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 02/26/2004 | US20040038857 Treating the cell with a cholinergic agonist in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from the cell, wherein the cell is a macrophage |
| 02/26/2004 | US20040038294 Hydrophilic chemilumescent acridinium labeling reagents |
| 02/26/2004 | US20040035293 Melt point is < 100 degrees c; provides distinct selectivities and reactivities because they are made of ions rather than molecules |
| 02/26/2004 | CA2495589A1 Azabicyclic compounds are central nervous system active agents |
| 02/25/2004 | EP1391457A1 Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391454A1 Substituted benzamide compounds with antihypertensive activity |
| 02/25/2004 | EP1391452A1 4-hydroxpiperidine derivative with analgetic activity |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1391450A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 02/25/2004 | EP1391203A1 Antitumor agents |
| 02/25/2004 | EP1390361A2 Melanocortin receptor ligands |
| 02/25/2004 | EP1390360A1 Crystalline form of omeprazole |
| 02/25/2004 | EP1390354A1 Triazinyl acrylamide derivatives as kinase inhibitors |
| 02/25/2004 | EP1390353A1 Triazole-derived kinase inhibitors and uses thereof |
| 02/25/2004 | EP1390352A1 Pyrimidine derivatives |
| 02/25/2004 | EP1390351A1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 02/25/2004 | EP1390350A1 Novel compounds |
| 02/25/2004 | EP1390349A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| 02/25/2004 | EP1390347A1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| 02/25/2004 | EP1390033A1 Farnesyl protein transferase inhibitors for treating cachexia |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | EP1222171B1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 02/25/2004 | EP1211246B1 Pyrimidine derivatives and herbicides containing the same |
| 02/25/2004 | EP1042296B1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 02/25/2004 | EP1040108B1 Ortho-anthranilamide derivatives as anti-coagulants |
| 02/25/2004 | EP1039908B1 Molecular dispersion composition with enhanced bioavailability |
| 02/25/2004 | EP1037607B1 Novel suppository form comprising an acid-labile active compound |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1478086A Process for crystallization of(R)-or(S)-lansoprazole |